LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

MRK

87.25

-0.84%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

MRK

87.25

-0.84%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

MRK

87.25

-0.84%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

MRK

87.25

-0.84%↓

LLY

877.97

+0.77%↑

UNH

526.48

-0.54%↓

ABBV

190.7

-1.19%↓

NVO

86.38

-0.88%↓

MRK

87.25

-0.84%↓

Search

Johnson and Johnson

Cerrado

Sector Salud

153.08 -0.26

Resumen

Variación precio

24h

Actual

Mínimo

152.8

Máximo

154.33

Métricas clave

By Trading Economics

Ingresos

737M

3.4B

Ventas

20M

23B

P/B

Media del Sector

24.52

59.362

BPA

2.04

Rentabilidad por dividendo

3.43

Margen de beneficio

15.235

EBITDA

-109M

5.3B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+9.11 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.43%

2.35%

Próximas Ganancias

15 abr 2025

Fecha Próximo Dividendo

4 mar 2025

Próxima Fecha de Ex Dividendo

18 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

366B

Apertura anterior

153.34

Cierre anterior

153.08

Noticias sobre sentimiento de mercado

By Acuity

36%

64%

111 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Johnson and Johnson Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

24 ene 2025, 07:00 UTC

Principales Noticias

Disasters Spawn New Businesses. The California Wildfires Will Do the Same. -- Barrons.com

22 ene 2025, 21:39 UTC

Ganancias

These Stocks Moved the Most Today: Netflix, Oracle, Nvidia, Arm, J&J, Procter & Gamble, Travelers, Seagate, and More -- Barrons.com

22 ene 2025, 19:41 UTC

Ganancias

These Stocks Are Moving the Most Today: Netflix, Oracle, Nvidia, Arm, J&J, Procter & Gamble, Travelers, Seagate, and More -- Barrons.com

22 ene 2025, 17:38 UTC

Charlas de Mercado
Ganancias

J&J's Forex Headwind in Outlook Surprised Investors -- Market Talk

22 ene 2025, 16:48 UTC

Ganancias

These Stocks Are Moving the Most Today: Netflix, Oracle, Nvidia, Arm, J&J, Procter & Gamble, Travelers, Seagate, and More -- Barrons.com

22 ene 2025, 14:51 UTC

Ganancias

These Stocks Are Moving the Most Today: Netflix, Oracle, Nvidia, Arm, J&J, Procter & Gamble, Travelers, Ford, and More -- Barrons.com

22 ene 2025, 14:09 UTC

Principales Noticias
Ganancias

Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth -- Barrons.com

22 ene 2025, 13:04 UTC

Ganancias

These Stocks Are Moving the Most Today: Netflix, Oracle, Nvidia, J&J, Procter & Gamble, United, Travelers, and More -- Barrons.com

22 ene 2025, 12:47 UTC

Ganancias

These Stocks Are Moving the Most Today: Netflix, Oracle, Nvidia, J&J, Procter & Gamble, United, Agilysys, and More -- Barrons.com

22 ene 2025, 12:34 UTC

Ganancias

Johnson & Johnson Earnings Narrowly Top But Dow Giant's Sales Guidance Light -- IBD

22 ene 2025, 12:15 UTC

Charlas de Mercado

J&J's 2025 Sales View Misses Wall Street Estimates -- Market Talk

22 ene 2025, 11:57 UTC

Charlas de Mercado
Ganancias

J&J 4Q Sales Rise on Demand for Cancer Drugs, Medical Devices -- Market Talk

22 ene 2025, 11:30 UTC

Ganancias

J&J's Earnings Beat Estimates But Guidance Is Mixed -- MarketWatch

22 ene 2025, 11:23 UTC

Principales Noticias
Ganancias

J&J Reports Strong Revenue and Profit But Faces Challenges in 2025 -- WSJ

22 ene 2025, 11:22 UTC

Principales Noticias
Ganancias

Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth -- Barrons.com

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson: Innovative Medicine 4Q Results Driven by In-Market Portfolio and Continued Uptake From Recently Launched Products, With 10 Brands Growing Double Digits >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson 4Q Worldwide MedTech Sales $8.19B >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson 4Q U.S. Sales $13.20B >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson: MedTech Business, With Addition of Shockwave Medical, Delivered Operational Sales Growth of 7.6% in 4Q >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson Sees 2025 Operational Sales of $90.9B-$91.7B >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson Sees 2025 Adjusted Operational EPS $10.75-$10.95 >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson Sees 2025 Adjusted Operational Sales Growth of 2.0%-3.0% >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson 4Q Adj EPS $2.04 >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson 4Q International Sales $9.32B >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson: 4Q Adj. EPS Factors in 22c for Acquired IPR&D Charges Related to V-Wave Acquisition >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson Sees 2025 Sales $89.2B-$90.0B >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson: MedTech Business 4Q Growth Driven by Electrophysiology, Abiomed and Wound Closure in General Surgery >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson Sees 2025 Adj EPS $10.50-Adj EPS $10.70 >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson 4Q Orthopaedics Sales $2.32B >JNJ

22 ene 2025, 11:20 UTC

Ganancias

Johnson & Johnson 4Q Worldwide Innovative Medicine Sales $14.33B >JNJ

Comparación entre iguales

Cambio de precio

Johnson and Johnson Esperado

Precio Objetivo

By TipRanks

9.11% repunte

Estimación a 12 meses

Media 167.5 USD  9.11%

Máximo 185 USD

Mínimo 152 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Johnson and Johnson Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

14 ratings

6

Comprar

8

Mantener

0

Vender

Puntuación técnica

By Trading Central

151.15 / 154.69Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

111 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Johnson and Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.